Tumor mutational burden (TMB) as a biomarker of response to immunotherapy in small cell lung cancer

被引：57
|
作者：
Boumber, Yanis [1 ,2 ,3 ]
机构：
[1] Fox Chase Canc Ctr, Program Mol Therapeut, 7701 Burholme Ave, Philadelphia, PA 19111 USA
[2] Fox Chase Canc Ctr, Dept Hematol Oncol, 7701 Burholme Ave, Philadelphia, PA 19111 USA
[3] Kazan Fed Univ, Insititute Fundamental Med & Biol, Kazan, Russia
来源：
JOURNAL OF THORACIC DISEASE | 2018年 / 10卷 / 08期
基金：
俄罗斯基础研究基金会;
关键词：
NIVOLUMAB PLUS IPILIMUMAB; TOPOTECAN; BLOCKADE;
D O I：
10.21037/jtd.2018.07.120
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：4689 / 4693
页数：5
相关论文
共 50 条
  • [1] Hot or Not: Tumor Mutational Burden (TMB) as a Biomarker of Immunotherapy Response in Genitourinary Cancers
    Halbert, Brian
    Einstein, David J.
    UROLOGY, 2021, 147 : 119 - 126
  • [2] Predicting response to immunotherapy in advanced non-small-cell lung cancer using tumor mutational burden radiomic biomarker
    He, Bingxi
    Dong, Di
    She, Yunlang
    Zhou, Caicun
    Fang, Mengjie
    Zhu, Yongbei
    Zhang, Henghui
    Huang, Zhipei
    Jiang, Tao
    Tian, Jie
    Chen, Chang
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [3] Tumor mutational burden profile (TMB) of oncogenic driver mutations in non small cell lung cancer
    Walker, Paul
    Sharma, Nitika
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [4] Clinical Potential of Tissue Tumor Mutational Burden (tTMB) and Blood TMB (bTMB) as a Biomarker in Non-Small Cell Lung Cancer
    Zhou, J.
    Zhou, J.
    Chen, X.
    Zhu, Y.
    Fang, L.
    Bao, Z.
    Liu, R.
    Cao, H.
    Sun, W.
    Zhang, T.
    Lin, J.
    Yu, B.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S370 - S370
  • [5] Relationship of tumor mutational burden (TMB) to immunotherapy response in metastatic renal cell carcinoma (mRCC).
    Maia, Manuel C.
    Almeida, Lorena
    Bergerot, Paulo Gustavo
    Dizman, Nazli
    Pal, Sumanta K.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [6] Clinical Implications of Circulating Tumor DNA Tumor Mutational Burden (ctDNA TMB) in Non-Small Cell Lung Cancer
    Chae, Young Kwang
    Davis, Andrew A.
    Agte, Sarita
    Pan, Alan
    Simon, Nicholas I.
    Iams, Wade T.
    Cruz, Marcelo R.
    Tamragouri, Keerthi
    Rhee, Kyunghoon
    Mohindra, Nisha
    Villaflor, Victoria
    Park, Wungki
    Lopes, Gilberto
    Giles, Francis J.
    ONCOLOGIST, 2019, 24 (06): : 820 - 828
  • [7] Non-Small Cell Lung Cancer as a Precision Oncology Paradigm: Emerging Targets and Tumor Mutational Burden (TMB)
    Tafe, Laura J.
    ADVANCES IN ANATOMIC PATHOLOGY, 2020, 27 (01) : 3 - 10
  • [8] The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker
    Jardim, Denis L.
    Goodman, Aaron
    Gagliato, Debora de Melo
    Kurzrock, Razelle
    CANCER CELL, 2021, 39 (02) : 154 - 173
  • [9] Candidate Biomarker of Response to Immunotherapy In Small Cell Lung Cancer
    Shen, Yili
    Liu, Zhicong
    Chen, Yi
    Shi, Xuefei
    Dong, Shunli
    Wang, Bin
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2025, 26 (02) : 73 - 83
  • [10] Tumor mutational burden as a tissue-agnostic biomarker for cancer immunotherapy
    Sung, Winnie W. Y.
    Chow, James C. H.
    Cho, William C. S.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2021, 14 (02) : 141 - 143
12345